Nvidia or Broadcom? Meta or Amazon?

Before NVIDIA Corp. NASDAQ: NVDA reported earnings on Nov. 19, the company got some bullish news. Anthropic, the host of the Claude AI large language model (LLM), announced it would commit $30 billion to use Microsoft's NASDAQ: MSFT Azure cloud services.

Sandisk Corporation remains a Strong Buy despite recent profit-taking and a sharp stock drop unrelated to fundamentals, which continue to improve. SNDK delivered strong Q1 results, with sales up 21% year-over-year, margin improvements, and robust guidance above analyst expectations for the next quarter. Growth is driven by AI and data center demand, new product innovation, and hyperscaler partnerships, while valuation remains attractive with a low forward PE.

DE braces for Q4 results as earnings estimates slip, segment forecasts diverge and cost pressures challenge its recent streak of surprises.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming January 16, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PERRIGO COMPANY PLC (PRGO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN T.

SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (NASDAQ: TLX), a commercial-stage biopharmaceutical company focused on medical imaging and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit, capping a tumultuous several months that saw the company's stock crater following revelations of a regulatory subpoena and an FDA rejection letter.

With the markets taking investors on a roller coaster ride of late, three technology stocks are on the downward slope today, including Vistra (NYSE: VST), AppLovin (Nasdaq: APP) and Oracle (NYSE: ORCL).

NEW YORK & TOKYO--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV® (enfortumab vedotin-ejfv), a Nectin-4 directed antibody-drug conjugate (ADC), in combination with the PD-1 inhibitor Keytruda® (pembrolizumab) or Keytruda QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), as neoadjuvant treatment and then continued after cystectomy.

Datadog Inc. (DDOG) shares up 128% since first Big Money outlier signal in 2020.

As the pet care industry experiences rapid growth, pharmaceutical companies are increasingly focusing on developing innovative treatments for companion animals.

Netflix shares jumped after its 10-for-1 stock split but sank after submitting a bid on Warner Bros. Discovery. YouTube has been winning the streaming war by gaining more viewers than Netflix and Disney+ combined. As YouTube gains share, Netflix is taking action as the TV market consolidates. Netflix's growth comes at a steep premium, and downward earnings revisions are on the rise.

GigaCloud Technology Inc. (GCT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

FEMSA faces near-term headwinds from weak Mexican consumer spending, underperforming drugstore and fuel businesses, and higher operating and tax expenses. Despite these challenges, FMX offers significant long-term growth potential through OXXO expansion in Mexico, Brazil, and the U.S., and its hard discount chain Bara. Shares appear undervalued below $100-$110, supporting a bullish long-term outlook, though near-term performance may remain sluggish for 6-12 months.

NEW YORK, NY / ACCESS Newswire / November 21, 2025 / Around the world, nations are discovering that security now has two fronts. The physical front that protects borders, and the institutional front that protects trust.

SAN FRANCISCO, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical “next generation” sleep apnea device, the Inspire V. The litigation zeroes in on the disparity between the company's confident assurances and the subsequent disastrous rollout that led to a dramatic stock crash.

Post Holdings, Inc. ( POST ) Q4 2025 Earnings Call November 21, 2025 9:00 AM EST Company Participants Daniel O'Rourke Robert Vitale - President, CEO & Director Jeff Zadoks - Executive VP and Chief Operating Officer Matt Mainer - Executive VP, CFO & Treasurer Conference Call Participants Andrew Lazar - Barclays Bank PLC, Research Division Thomas Palmer - JPMorgan Chase & Co, Research Division Matthew Smith - Stifel, Nicolaus & Company, Incorporated, Research Division Scott Marks - Jefferies LLC, Research Division Michael Lavery - Piper Sandler & Co., Research Division Marc Torrente - Wells Fargo Securities, LLC, Research Division John …

AXP is elevating its travel and lifestyle services into a broader, experience-driven growth engine for premium members.

ADSK's Q3 performance is likely to have benefited from AECO strength and recurring revenue gains, while FX pressures and its new transaction model may weigh.

ITT (ITT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Crown (CCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).